Back to search
FDAFDA · Food and drugs·Recall number D-0200-2017

Neostigmine Methylsulfate 5 mg/5 mL Injection Solution, 5 mL (1 mg/mL) Single-Dose Syringe, For Slow IV Use, Rx Only, Cantrell Drug Co. 7321 Cantrell Rd. Little Rock, AR 72207, NDC 52533-046-15

Published December 21, 2016 · Recall initiated: November 18, 2016

Summary

FDA records drug Class II recall D-0200-2017, published December 21, 2016 and initiated November 18, 2016. Recalling firm: Cantrell Drug Company; Status: Terminated; Reported quantity: 24,547 syringes; Lot: Lot: 8997 BUD: 12/1/2016, Lot: 9246 BUD: 1/23/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Cantrell Drug Company
Distributor
Nationwide
Lot
Lot: 8997 BUD: 12/1/2016, Lot: 9246 BUD: 1/23/2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Neostigmine Methylsulfate 5 mg/5 mL Injection Solution, 5 mL (1 mg/mL) Single-Dose Syringe, For Slow IV Use, Rx Only, Cantrell Drug Co. 7321 Cantrell Rd. Little Rock, AR 72207, NDC 52533-046-15 recalled?

Yes. FDA published recall D-0200-2017 on December 21, 2016. Reported hazard: Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release